Targeting the HIF1A-UCA1-PTBP3 axis: a potential therapeutic strategy for head and neck cancer. Sim LC, Kuo YZ, Cheng TC, Chen CL, et al. BMC Cancer 2025;25:1536.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sim LC, Kuo YZ, Cheng TC, Chen CL, et al. Targeting the HIF1A-UCA1-PTBP3 axis: a potential therapeutic strategy for head and neck cancer. BMC Cancer 2025;25:1536.
PMID: 41068676